Bramante Biologics (YC X25) Revenue
Biotechnology Research • 
Cambridge, Massachusetts, United States • 1-10 Employees
$
Bramante Biologics (YC X25) revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $273,776 |
| Total funding | $500,000 |
Key Contact at Bramante Biologics (YC X25)
Scott Stankey
Co-Founder
Company overview
| Headquarters | Cambridge, Massachusetts, United States |
| Website | |
| NAICS | 541714 |
| Founded | 2024 |
| Employees | 1-10 |
Bramante Biologics (YC X25) Email Formats
Bramante Biologics (YC X25) uses 1 email format. The most common is {first initial} (e.g., j@bramantebio.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial} | j@bramantebio.com | 100% |
About Bramante Biologics (YC X25)
US-based biologics CDMO for protein therapeutics. Part of the YCombinator X25 batch.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Founder/Owner
Employees by Department
Bramante Biologics (YC X25) has 1 employees across 1 departments.
Departments
Number of employees
United Kingdom
Saudi Arabia
AustraliaFrequently asked questions
Bramante Biologics (YC X25) is located in Cambridge, Massachusetts, US.
Bramante Biologics (YC X25) generates an estimated annual revenue of $85,555. This revenue figure reflects the company's market position and business performance in its industry.
Bramante Biologics (YC X25) has an estimated valuation of $273,776. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
Bramante Biologics (YC X25) was founded in 2024, making it 2 years old. The company has established itself as a significant player in its industry over this time.
Bramante Biologics (YC X25) has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
Bramante Biologics (YC X25) has raised a total of $500,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.
4.8
40,000 users
